NF1 and neoplasm: It is possible that NK cells in Nf1+/− mice may be compensated for by reduced ERK phosphorylation and rescue of MAPK/ERK signaling in the tumor microenvironment; thus, Nf1+/− mice would exhibit an increase in antitumor immunity and have enhanced survival.